The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

Monash University researchers are assessing a new drug that could be a game changer for the dementia that has struck US actor Bruce Willis, and ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

Now, for the first time, a new group of drugs called monoclonal antibodies have been shown to slow down the decline in thinking and memory in Alzheimer’s patients, the most common form of dementia.

We all know about Alzheimer’s Disease, in fact, many of us know someone who has been impacted by it. But there is another ...

Lewy Body Dementia is progressive, and causes uncontrollable tremors, problems with memory, attention, and sleep.

Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...

New study to investigate non-invasive treatment for dementia and Parkinson’s - Researchers will look at whether treatment can ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

Cognitive decline may increase an older person's risk for a fall, while the trauma that follows a fall may also speed up ...